Literature DB >> 8897501

Effect of immunosuppressive drug regimens on acute and chronic murine toxoplasmosis.

M H Sumyuen1, Y J Garin, F Derouin.   

Abstract

To evaluate the potential risk of dissemination or reactivation of toxoplasmosis following the administration of immunosuppressive therapy we examined the effect of corticoids, azathioprine, and cyclosporine given alone or in combination on the course of murine acute and chronic toxoplasmic infection. Swiss Webster mice were infected perorally with a high-level inoculum of cysts of the C strain of Toxoplasma gondii. The evolution of the kinetics of parasite loads in the blood, brain, and lungs of infected and immunosuppressed mice was then sequentially followed. In mice with orally acquired infections initiated 2 days after the beginning of drug treatment, immunosuppression led to the persistence of parasites, especially in the lungs, which was most marked in mice treated with azathioprine and/or cortisol acetate. Administration of immunosuppressive therapy in mice previously infected with T. gondii resulted in a brief resurgence of parasite loads when treatment was started early after infection. Finally, under our experimental conditions we found that the immunosuppressive drugs that were given altered the natural course of infection with a prolonged persistence of parasites in the lungs but did not significantly affect parasite loads in the brain or lead to disseminated infection with detectable parasitemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897501     DOI: 10.1007/s004360050185

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  9 in total

Review 1.  Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.

Authors:  J P Dubey; D S Lindsay; C A Speer
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Toxoplasma gondii meningoencephalitis without cerebral MRI findings in a patient with ulcerative colitis under immunosuppressive treatment.

Authors:  S F Assimakopoulos; V Stamouli; D Dimitropoulou; A Spiliopoulou; G Panos; E D Anastassiou; M Marangos; I Spiliopoulou
Journal:  Infection       Date:  2015-01-27       Impact factor: 3.553

Review 3.  Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity.

Authors:  Andrew J Neville; Sydney J Zach; Xiaofang Wang; Joshua J Larson; Abigail K Judge; Lisa A Davis; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

4.  Preventive effect of pidotimod on reactivated toxoplasmosis in mice.

Authors:  Xing-Xing Huo; Lin Wang; Zhao-Wu Chen; He Chen; Xiu-Cai Xu; Ai-Mei Zhang; Xiao-Rong Song; Qing-Li Luo; Yuan-Hong Xu; Yu Fu; Hua Wang; Jian Du; Yi-Hong Cai; Zhao-Rong Lun; Fang-Li Lu; Yong Wang; Ji-Long Shen
Journal:  Parasitol Res       Date:  2013-06-18       Impact factor: 2.289

Review 5.  Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review.

Authors:  Mahbobeh Montazeri; Saeed Mehrzadi; Mehdi Sharif; Shahabeddin Sarvi; Shayesteh Shahdin; Ahmad Daryani
Journal:  Parasitol Res       Date:  2018-08-08       Impact factor: 2.289

Review 6.  Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.

Authors:  Ildiko Rita Dunay; Kiran Gajurel; Reshika Dhakal; Oliver Liesenfeld; Jose G Montoya
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

7.  Toxoplasma gondii infection in the peritoneal macrophages of rats treated with glucocorticoids.

Authors:  Tao Wang; Jiang-Mei Gao; Si-Qi Yi; Guo-Qing Geng; Xiao-Jie Gao; Ji-Long Shen; Fang-Li Lu; Yan-Zi Wen; Geoff Hide; Zhao-Rong Lun
Journal:  Parasitol Res       Date:  2013-11-19       Impact factor: 2.289

8.  Activated microglia contribute to neuronal apoptosis in Toxoplasmic encephalitis.

Authors:  Yi-hua Zhang; He Chen; Ying Chen; Lu Wang; Yi-hong Cai; Min Li; Hui-qin Wen; Jian Du; Ran An; Qing-li Luo; Xue-long Wang; Zhao-Rong Lun; Yuan-hong Xu; Ji-long Shen
Journal:  Parasit Vectors       Date:  2014-08-15       Impact factor: 3.876

9.  Azathioprine-induced toxoplasma gondii infection in a patient with Crohn's disease with NUDT15 variation: A case report.

Authors:  Yanan Wu; Yuyong Tan; Dalian Ou; Xuehong Wang; Yongjun Wang
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.